ArticleHaematologica2021
Time to reconsider CD33 single nucleotide polymorphism in the response to gemtuzumab ozogamicin.
Jatinder K Lamba et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleHaematologica2021
Jatinder K Lamba et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.